Jun 10, 2020
International Atherosclerosis Society Issues Call to Action to Improve Lipid Management Based on Survey Results to Address Patients' Residual Risk
Mar 30, 2020
Regeneron Announces American College of Cardiology Presentation of Positive Phase 3 Evinacumab Results in Patients with Severe Inherited Form of High Cholesterol
Mar 28, 2020
Novartis new analysis further showed durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment
Mar 18, 2020
Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiran, an investigational first-in-class siRNA cholesterol-lowering therapy
Feb 10, 2020
Yuyu's First Generic Newmacor's 5-year Cumulative Sales Surpasses 40 Million Capsules
Jan 02, 2020
Global Call To Action on Familial Hypercholesterolemia Aims to Improve Diagnosis and Treatment Worldwide
Dec 20, 2019
HealthWell Foundation Launches Fund to Provide Financial Assistance to Medicare Patients with Hypercholesterolemia
Nov 11, 2019
Amgen Highlights Data To Be Presented At AHA 2019 Across Cardiovascular Portfolio
Sep 17, 2019
Familial Hypercholesterolemia Patients at High Risk for Cardiovascular Events Despite Treatment
Aug 28, 2019
New Amgen Data To Be Presented At ESC Congress 2019 Highlight Additional Evidence For Repatha® (Evolocumab) Effectiveness In Cardiovascular Disease Across Multiple Patient Groups
Aug 14, 2019
Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol
Jul 23, 2019
Individuals Had More Heart Attacks and Strokes When Cholesterol-lowering Drug Prescription Was Rejected or Unfilled
May 15, 2019
HDL Therapeutics Announces Positive Data From Registration Trial of PDS-2(TM) System in Homozygous Familial Hypercholesterolemia
Apr 11, 2019
FIND FH® Effectively Identified Individuals with Possible Familial Hypercholesterolemia (FH) in Electronic Health Records
Apr 11, 2019
FH Foundation Expands FIND FH® to Speed Diagnosis of Individuals with Homozygous Familial Hypercholesterolemia
Mar 20, 2019
Innovent Announces First Patient Dosed in a Phase IIa Clinical Study of IBI306, an Anti-PCSK9 Monoclonal Antibody
Mar 15, 2019
Amgen Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke
Mar 06, 2019
New Data From Amgen To Be Presented At ACC.19 Continues To Build Evidence For Repatha® (evolocumab) Across Multiple Patient Populations
Mar 06, 2019
Familial Chylomicronemia Syndrome Foundation Completes Follow-up Discussion with FDA in Effort to Find Path Forward for Investigational Treatment
Feb 25, 2019
Jury Upholds Amgen's Patents On Repatha® (evolocumab)